» Articles » PMID: 15741347

Helix Periodicity, Topology, and Dynamics of Membrane-associated Alpha-synuclein

Overview
Journal Protein Sci
Specialty Biochemistry
Date 2005 Mar 3
PMID 15741347
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

The protein alpha-Synuclein (aS) is a synaptic vesicle-associated regulator of synaptic strength and dopamine homeostasis with a pathological role in Parkinson's disease. The normal function of aS depends on a membrane-associated conformation that is adopted upon binding to negatively charged lipid surfaces. Previously we found that the membrane-binding domain of aS is helical and suggested that it may exhibit an unusual structural periodicity. Here we present a study of the periodicity, topology, and dynamics of detergent micelle-bound aS using paramagnetic spin labels embedded in the micelle or attached to the protein. We show that the helical region of aS completes three full turns every 11 residues, demonstrating the proposed 11/3 periodicity. We also find that the membrane-binding domain is partially buried in the micelle surface and bends toward the hydrophobic interior, but does not traverse the micelle. Deeper submersion of certain regions within the micelle, including the unique lysine-free sixth 11-residue repeat, is observed and may be functionally important. There are no long-range tertiary contacts within this domain, indicating a highly extended configuration. The backbone dynamics of the micelle-bound region are relatively uniform with a slight decrease in flexibility observed toward the C-terminal end. These results clarify the topological features of aS bound to membrane-mimicking detergent micelles, with implications for aS function and pathology.

Citing Articles

Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies.

Li B, Dettmer U Neurobiol Dis. 2024; 201:106646.

PMID: 39181187 PMC: 11760337. DOI: 10.1016/j.nbd.2024.106646.


α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies.

Bigi A, Cascella R, Cecchi C Neural Regen Res. 2023; 18(11):2332-2342.

PMID: 37282450 PMC: 10360081. DOI: 10.4103/1673-5374.371345.


Postsynaptic synucleins mediate endocannabinoid signaling.

Albarran E, Sun Y, Liu Y, Raju K, Dong A, Li Y Nat Neurosci. 2023; 26(6):997-1007.

PMID: 37248337 PMC: 10244176. DOI: 10.1038/s41593-023-01345-0.


Non-uniform sampling of similar NMR spectra and its application to studies of the interaction between alpha-synuclein and liposomes.

Shchukina A, Schwarz T, Nowakowski M, Konrat R, Kazimierczuk K J Biomol NMR. 2023; 77(4):149-163.

PMID: 37237169 PMC: 10406685. DOI: 10.1007/s10858-023-00418-3.


Ingenuity pathway analysis of -synuclein predicts potential signaling pathways, network molecules, biological functions, and its role in neurological diseases.

Suthar S, Lee S Front Mol Neurosci. 2022; 15:1029682.

PMID: 36523604 PMC: 9744789. DOI: 10.3389/fnmol.2022.1029682.


References
1.
Bisaglia M, Tessari I, Pinato L, Bellanda M, Giraudo S, Fasano M . A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles. Biochemistry. 2005; 44(1):329-39. DOI: 10.1021/bi048448q. View

2.
Jensen P, Nielsen M, Jakes R, Dotti C, Goedert M . Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem. 1998; 273(41):26292-4. DOI: 10.1074/jbc.273.41.26292. View

3.
Segrest J, Jones M, Klon A, Sheldahl C, Hellinger M, De Loof H . A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J Biol Chem. 1999; 274(45):31755-8. DOI: 10.1074/jbc.274.45.31755. View

4.
Liscovitch M, Czarny M, Fiucci G, Tang X . Phospholipase D: molecular and cell biology of a novel gene family. Biochem J. 2000; 345 Pt 3:401-15. PMC: 1220771. View

5.
Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho W, Castillo P . Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000; 25(1):239-52. DOI: 10.1016/s0896-6273(00)80886-7. View